Diabetic kidney disease: The fourth pharmacological pillar may be semaglutide

Authors

Katherine Esposito (ORCID: https://orcid.org/0000-0002-3652-5154)
Dario Giugliano (ORCID: https://orcid.org/0000-0002-9377-873X)
Luca De Nicola (ORCID: https://orcid.org/0000-0001-8532-0182)

Institutions

University of Campania "Luigi Vanvitelli" (IT)

Publication Details

Journal: Diabetes Obesity and Metabolism
Published: 2024-09-02
DOI: https://doi.org/10.1111/dom.15892
Citations: 1
Primary Topic: Diabetes Treatment and Management
Type: article
Field-Weighted Citation Impact: 0.36

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Diabetic kidney disease: The fourth pharmacological pillar may be semaglutide

Katherine Esposito, Dario Giugliano, Luca De Nicola

Sep 2, 2024

1 citations

Diabetes Obesity and Metabolism

Diabetes Treatment and Management

0.36

article

Diabetic kidney disease: The fourth pharmacological pillar may be semaglutide

Katherine Esposito, Dario Giugliano, Luca De Nicola

September 2, 2024article en

1 citations

Abstract

No abstract available for this paper.

Diabetes Obesity and MetabolismVol. 26(11)

University of Campania "Luigi Vanvitelli" (IT)

Good health and well-being

Openalex Percentile: Top 34%

Diabetes Treatment and Management

0.36

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Diabetic kidney disease: The fourth pharmacological pillar may be semaglutide — Katherine Esposito, Dario Giugliano, et al. · Diabetes Obesity and Metabolism (2024) | TGRS Research Map | TGRS